EuroSciCon meeting on bioprocess miniaturization: development and optimization 26 November 2013, London, UK

The impetus to accelerate process development in the biopharmaceutical industry is driven by reducing costs and time to market. Shortening development times is critical to the success of the industry [1]. The miniaturization of bioprocessing assists in the generation of quantitative data, fast and efficiently. This helps inform bioprocess design and speeds translation to the manufacturing scale. The meeting reviewed individual operations in the bioprocess workflow highlighting the state-of-the-art in technology and research and innovation. A brief overview of the themes covered is discussed below.